结合杜皮卢马布和过敏原特异性免疫疗法在严重耐火性亚托皮炎的治疗
Jemin Kim1, Jihee Boo1, Hyunwoo Jang2
1Department of Dermatology, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea.
Allergy, asthma & immunology research
|December 2, 2024
概括
将dupilumab与皮下免疫疗法 (SCIT) 结合使用,对严重的亚托皮性皮炎 (AD) 有望. 这种治疗减少了AD的严重程度,并改善了在耐药性AD患者的研究中具有轻微副作用的免疫标志物.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 过敏研究 研究过敏
背景情况:
- 像喘和过敏性鼻炎这样的无形性疾病从将生物药物与过敏原免疫治疗相结合中受益.
- 在组合治疗的背景下,亚托皮炎 (AD) 的研究较少.
- 严重的AD耐标准治疗,是一个重大的临床挑战.
研究的目的:
- 调查重症阿尔茨海默氏症患者将杜皮卢马布与皮下免疫治疗 (SCIT) 结合使用的疗效和安全性.
- 评估这种联合治疗对疾病严重程度和免疫标记物的影响.
- 评估在治疗不耐药的阿尔茨海默氏症患者中联合杜皮卢马布和SCIT的安全性.
主要方法:
- 韩国首尔Severance医院对严重AD患者的单中心回顾分析.
- 患者接受了复利马布和SCIT联合治疗,单独使用复利马布或单独使用SCIT.
- 纳入标准:严重的阿尔茨海默病诊断,对室内灰尘虫过敏原的特定IgE,以及≥18个月的随访.
- 收集的数据:湿疹区域和严重性指数 (EASI) 评分,血清生物标志物和144周的不良事件.
主要成果:
- 在组合治疗组中观察到EASI得分的显著改善.
- 血清生物标志物的有利变化,包括减少总IgE和特定IgE水平.
- 发现过敏原特异性IgG4水平增加,表明免疫反应发生了转变.
- 所有患者都经历了轻微的,暂时的副作用,不需要停止治疗.
结论:
- 结合治疗与dupilumab和SCIT是一个有希望的选择,严重的,治疗不耐药的AD.
- 这种方法有效地减少了AD的严重程度,并诱导了有益的免疫变化.
- 组合疗法显示出有利的安全性,与单一疗法相美.
相关概念视频
Allergic Reactions
27.2K
Overview
27.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
237
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
237
Hypersensitivities
512
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
512
Allergic Drug Reactions
812
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
812
Antiasthma Drugs: Leukotriene Modifiers
243
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
243
Drugs Used in Lower Respiratory Disorders: Overview
349
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
349


